Sabra Healthcare REIT, Inc. (SBRA) Shares Sold by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH decreased its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 41.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,500 shares of the real estate investment trust’s stock after selling 14,400 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Sabra Healthcare REIT were worth $573,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Sabra Healthcare REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock valued at $106,000 after buying an additional 471 shares during the period. Bank of Montreal Can increased its stake in Sabra Healthcare REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock valued at $109,000 after buying an additional 1,191 shares during the period. Russell Investments Group Ltd. acquired a new stake in Sabra Healthcare REIT during the fourth quarter valued at $120,000. Ameritas Investment Partners Inc. acquired a new stake in Sabra Healthcare REIT during the first quarter valued at $156,000. Finally, Silvercrest Asset Management Group LLC acquired a new stake in Sabra Healthcare REIT during the fourth quarter valued at $232,000. Institutional investors and hedge funds own 99.47% of the company’s stock.

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) traded up 0.98% during trading on Friday, reaching $23.67. 2,430,689 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of $24.24 and a 200 day moving average price of $25.53. Sabra Healthcare REIT, Inc. has a 12-month low of $19.30 and a 12-month high of $29.10. The company has a market capitalization of $1.55 billion, a P/E ratio of 16.36 and a beta of 1.00.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, May 8th. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by $0.33. The company had revenue of $62.65 million during the quarter, compared to analyst estimates of $63.47 million. Sabra Healthcare REIT had a net margin of 40.22% and a return on equity of 10.35%. Sabra Healthcare REIT’s revenue for the quarter was up .1% on a year-over-year basis. During the same period in the prior year, the business earned $0.54 EPS. Equities analysts expect that Sabra Healthcare REIT, Inc. will post $1.20 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 31st. Shareholders of record on Thursday, May 18th were given a $0.43 dividend. The ex-dividend date of this dividend was Tuesday, May 16th. This represents a $1.72 dividend on an annualized basis and a yield of 7.27%. This is a positive change from Sabra Healthcare REIT’s previous quarterly dividend of $0.42. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 119.45%.

ILLEGAL ACTIVITY NOTICE: “Sabra Healthcare REIT, Inc. (SBRA) Shares Sold by Fort Washington Investment Advisors Inc. OH” was originally reported by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://www.themarketsdaily.com/2017/06/16/sabra-health-care-reit-inc-sbra-shares-sold-by-fort-washington-investment-advisors-inc-oh-updated-updated.html.

Several analysts recently weighed in on SBRA shares. Cantor Fitzgerald lifted their price objective on Sabra Healthcare REIT from $25.00 to $30.00 and gave the company an “overweight” rating in a report on Tuesday, February 28th. Zacks Investment Research downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Thursday, June 8th. Jefferies Group LLC restated a “hold” rating and issued a $28.00 price objective on shares of Sabra Healthcare REIT in a report on Friday, May 12th. Stifel Nicolaus lifted their price objective on Sabra Healthcare REIT from $24.00 to $26.00 and gave the company a “hold” rating in a report on Monday, February 27th. Finally, Canaccord Genuity restated a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a report on Tuesday, May 9th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $27.71.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply